History of the Development of Antiemetic Guidelines at Mayo Clinic Rochester

This publication has 31 references indexed in Scilit:

• Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: Ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam
  Annals of Oncology, 1996
• Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis
  Annals of Oncology, 1995
• Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy
  European Journal Of Cancer, 1994
• Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis
  British Journal of Cancer, 1994
• Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis
  Annals of Oncology, 1994
• Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients
  Annals of Oncology, 1994
• Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis
  The Lancet, 1992
• Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast Cancer
  Oncology, 1992
• Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?
  BMJ, 1991
• Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.
  Journal of Clinical Oncology, 1991